Phylogenetic analysis of an off-seasonal influenza virus A (H3N2) in Niigata, Japan, 2010

Japanese Journal of Infectious Diseases

Volumn 64, Issue 3, 2011, Pages 237-241

  Dapat, Clyde ^a   Suzuki, Yasushi ^a   Kon, Miyako ^b   Tamura, Tsutomu ^b   Saito, Reiko ^a   Dapat, Isolde C ^a   Yamazaki, Osamu ^c   Odagiri, Takato ^d   Fujisaki, Seiichiro ^d   Suzuki, Hiroshi ^e  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b Niigata Prefectural Institute of Public Health And Environmental Sciences   (Japan)

^c Niigata Prefectural Government   (Japan)

^d NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^e NIIGATA SEIRYO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 ACETAMIDO 5 AMINO 3 (1 ETHYLPROPOXY) 1 CYCLOHEXENE 1 CARBOXYLIC ACID; AMANTADINE; MATRIX PROTEIN; NONSTRUCTURAL PROTEIN 1; NONSTRUCTURAL PROTEIN 2; NUCLEOCAPSID PROTEIN; POLYMERASE ACIDIC PROTEIN; POLYMERASE BASIC PROTEIN 1; POLYMERASE BASIC PROTEIN 2; PROTEIN M2; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS SIALIDASE; ZANAMIVIR;

AGED; AMINO ACID SUBSTITUTION; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; CONTROLLED STUDY; GENE MUTATION; GENETIC REASSORTMENT; GENOME ANALYSIS; GERIATRIC HOSPITAL; HEMAGGLUTINATION INHIBITION TEST; HUMAN; IC 50; INFLUENZA VIRUS A H3N2; JAPAN; M2 GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; REAL TIME POLYMERASE CHAIN REACTION; VIRUS GENE; VIRUS GENOME; VIRUS ISOLATION; VIRUS RECOMBINATION; VIRUS RESISTANCE;

AGED, 80 AND OVER; AMANTADINE; ANTIVIRAL AGENTS; DISEASE OUTBREAKS; DRUG RESISTANCE, VIRAL; GENOME, VIRAL; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; INHIBITORY CONCENTRATION 50; JAPAN; MICROBIAL SENSITIVITY TESTS; MUTATION, MISSENSE; PHYLOGENY; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SEROTYPING; VIRAL MATRIX PROTEINS;

EID: 79958065580     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Socan, M., Prosenc, K., Tevz-Cizej, N. (2010): Influenza A(H1N1) outbreak in a long-term care facility for severely handicapped residents, Slovenia, March-April 2009. Euro Surveill., 15(21), 19577.
2. Harper, S., Bradley, J., Englund, J., et al. (2009): Seasonal influenza in adults and children-diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin. Infect. Dis., 48, 1003-1032.
3. Patriarca, P., Arden, N., Koplan, J., et al. (1987): Prevention and control of type A influenza infections in nursing homes. Benefits and costs of four approaches using vaccination and amantadine. Ann. Intern. Med., 107, 732-740.
4. Dharan, N., Patton, M., Siston, A., et al. (2009): Outbreak of antiviral drug-resistant influenza a in long-term care facility, Illinois, USA, 2008. Emerg. Infect. Dis., 15, 1973-1976.
5. World Health Organization (2010): Recommended viruses for influenza vaccines for use in the 2010-2011 northern hemisphere influenza season. Wkly. Epidemiol. Rec., 85, 81-92.
6. Nakauchi, M., Yasui, Y., Miyoshi, T., et al. (2010): One-step real-time reverse transcription-PCR assays for detecting and subtyping pandemic influenza A/H1N1 2009, seasonal influenza A/H1N1, and seasonal influenza A/H3N2 viruses. J. Virol. Methods, 171, 156-162.
7. Suzuki, Y., Saito, R., Zaraket, H., et al. (2010): Rapid and specific detection of amantadine-resistant influenza A viruses with a Ser31Asn mutation by the cycling probe method. J. Clin. Microbiol., 1, 57-63.
8. Hurt, A., Barr, I., Hartel, G., et al. (2004): Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir. Antiviral Res., 62, 37-45.
9. Dapat, C., Suzuki, Y., Saito, R., et al. (2010): Rare influenza A (H3N2) variants with reduced sensitivity to antiviral drugs. Emerg. Infect. Dis., 16, 493-496.
10. Ghedin, E., Sengamalay, N., Shumway, M., et al. (2005): Largescale sequencing of human influenza reveals the dynamic nature of viral genome evolution. Nature, 437, 1162-1166.
11. Tamura, K., Dudley, J., Nei, M., et al. (2007): MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol. Biol. Evol., 24, 1596-1599.
12. Infectious Disease Surveillance Cencer, National Institute of Infectious Diseases. Isolation/Detection of Influenza Virus in Japan, from Week 19 (May 4-10) of 2009 to Week 38 (September 20-26) of 2010. Online at http://idsc.nih.go.jp/iasr/influ-e.html. Accessed 1 October 2010.
13. Wiley, D., Wilson, I. and Skehel, J. (1981): Structural identification of the antibody-binding sites of Hong Kong influenza hae magglutinin and their involvement in antigenic variation. Nature, 289, 373-378.
14. Barr, I.G., Komadina, N., Hurt, A., et al. (2003): Reassortants in recent human influenza A and B isolates from South East Asia and Oceania. Virus Res., 98, 35-44.
15. Furuse, Y., Suzuki, A., Kamigaki, T., et al. (2009): Reversion of influenza A (H3N2) virus from amantadine resistant to amantadine sensitive by further reassortment in Japan during the 2006-to-2007 influenza season. J. Clin. Microbiol., 47, 841-844.
16. Xu, X., Lindstrom, S.E., Shaw, M.W., et al. (2004): Reassortment and evolution of current human influenza A and B viruses. Virus Res., 103, 55-60.
17. Zaraket, H., Saito, R., Suzuki, Y., et al. (2010): Genomic events contributing to the high prevalence of amantadine-resistant influenza A/H3N2. Antivir. Ther., 15, 307-319.